Research for evaluation of efficacy and safety of DAA therapy in HIV/HCV co-infected patients disorders
Not Applicable
Recruiting
- Conditions
- Chronic hepatitis C
- Registration Number
- JPRN-UMIN000027371
- Lead Sponsor
- ational Center for Global Health and Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with non-compensated cirrhosis Patients with severe renal impairment (eGFR<30ml/minute/1.73m2) Patients with HBs antigen positive Patients who have active opportunistic infection Other drugs are adequate for the patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method